Keywords: Mucinous breast carcinoma; Her2 positive; Resistance trastuzumab;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Breast cancer; Cardiac outcomes; Chemotherapy; HER2 positive; Trastuzumab;
HER2-positive breast cancer: Current and new therapeutic strategies
Keywords: HER2 positive; Targeted therapies; Drugs in development; Advanced breast cancer;
Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors
Keywords: HER2 positive; HER2-TK; HER2-Tyrosine Kinase inhibitors; Naringenin; Hesperetin; Anti-cancer agents; Flavonoids
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature
Keywords: Advanced Breast cancer; Her2 positive; Treatment; Trastuzumab emtansine
A Prospective Randomised Phase III Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated with Trastuzumab for Metastatic Breast Cancer - Anglo Celtic VII
Keywords: Breast cancer; CNS metastases; HER2 positive; radiotherapy;
Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumab
Keywords: Trastuzumab; HER2 positive; Metastatic breast cancer; Long-term remission; Survival;
Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer
Keywords: Tykerb/Tyverb Evaluation After Chemotherapy (TEACH) trial; Health related quality of life; HRQOL; Adjuvant breast cancer; Human Epidermal Growth Factor Receptor (HER2); HER2 positive; Early breast cancer; Lapatinib; Placebo; SF-36
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial
Keywords: HER2 positive; Lapatinib; Metastatic breast cancer; Vinorelbine;
Time to stop operating on breast cancer patients with pathological complete response?
Keywords: Surgery; Breast cancer; Neoadjuvant; HER2 positive; Chemotherapy
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells
Keywords: HER2-amplicon; Breast cancer; HER2 positive; siRNA; Trastuzumab; Lapatinib; Drug resistance; 17q12; Gene silencing; Functional screen
Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast Cancer
Keywords: BC; breast cancer; DFI; disease-free interval; ER; estrogen receptor; HER2; human epidermal growth factor receptor 2; HER2+; HER2 positive; HR+; hormone receptor positive; mBC; metastatic breast cancer; OS; overall survival; PR; progesterone receptor; TN;
Advances in Molecular and Clinical Subtyping of Breast Cancer and Their Implications for Therapy
Keywords: Breast cancer; Intrinsic subtypes; Endocrine therapy; HER2 positive; Triple negative; Resistance;
Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: A pilot study
Keywords: Metabolomics; Breast cancer; Metastatic; HER2 positive; Prediction
HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component
Keywords: DCIS; Breast cancer; HER2 positive; Coexisting invasion; Predictor